Windward Bio, an Immunology Biotech, Completes Nasdaq IPO

AI-generated NewsSnap summary based on source reporting.
Published: 2026-11-14
Category: business
Source: Stock Analysis / Endpoints News
Original source

Clinical-stage biotechnology firm Windward Bio (Nasdaq: WWB), a Qiming Venture Partners portfolio company, successfully listed on Nasdaq on November 13, 2026. The company's Initial Public Offering (IPO) was priced at $17.00 per share. This marks a significant milestone for the immunology biotech, providing capital for its ongoing development.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai